Biotech Archives - Page 755 of 795

1 minute read

Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead

August 5, 12:32 AM

Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund.

ARKK

3 minute read

Recap Of Thursday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 4, 6:07 PM

ARQT

1 minute read

FDA
News

Akebia Therapeutics Announces Initial Findings From Investigator-Sponsored Clinical Study Evaluating Vadadustat For Prevention And Treatment Of Acute Respiratory Distress Syndrome (ARDS) In Subjects With COVID-19 And Hypoxemia (VSTAT)

By Benzinga Newsdesk

August 4, 5:27 PM

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced initial findings from an

AKBA

1 minute read

Marker Therapeutics Shares Jump 60 Percent As FDA Announced Clearance To Blood Cell Cancer Study

By Ragothaman Srinivasan

August 4, 5:01 PM

The U.S. Food and Drug Administration (FDA) announced clearance to Marker Therapeutics’ (NASDAQ: MRKR) Investigational New Drug (IND) application for MT-601 for the treatment of patients with relapsed/refractory non-Hodgkin lymphoma.

MRKR

1 minute read

Alzamend Neuro Stock Pops After Benzinga Exclusive On Cognition Therapeutics Alzheimer’s Data

By Adam Eckert

August 4, 4:05 PM

Shares of biopharmaceutical company Alzamend Neuro Inc (NASDAQ: ALZN) are soaring Thursday afternoon after Cognition Therapeutics Inc (NASDAQ: CGTX) shares surged following the presentation of a proteomic

ALZN

2 minute read

US Officials Declare Health Emergency Over Monkeypox Outbreak As Cases Cross 6,000 Mark: Report

By Vandana Singh

August 4, 3:01 PM

The Biden administration has officially declared monkeypox a public health emergency as cases continue to rise in the U.S., the Wall Street Jour

AEMD

1 minute read

Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China

By Vandana Singh

August 4, 2:19 PM

Innovent Biologics Inc (OTC:IVBXF) and Sanofi SA (NASDAQ:SNY) have collaborated to develop and commercialize two Sanofi clinical-stage oncology assets – Phase 3 SAR408701…

IVBXF

1 minute read

Pfizer Cuts Late-Stage Asset For Rare Cardiovascular Acquired Via $11.4B Array acquisition

By Vandana Singh

August 4, 1:47 PM

Pfizer Inc (NYSE:PFE) announced that an interim futility analysis of the global Phase 3 trial, REALM-DCM of PF-07265803, indicated…

PFE

1 minute read

Novavax Starts Late-Stage COVID-19 Vaccine Study In Children Below 11 Years

By Vandana Singh

August 4, 12:44 PM

Novavax Inc (NASDAQ:NVAX) has initiated its Phase 2b/3 Hummingbird trial to evaluate the safety, effectiveness, and efficacy of two doses of…

NVAX

1 minute read

Rain Therapeutics Concludes Enrolment In Late-Stage Tissue Cancer Study, Expects Topline Data In H1 2023

By Ragothaman Srinivasan

August 4, 12:37 PM

Rain Therapeutics (NASDAQ: RAIN) has completed patient enrolment in its Phase 3 MANTRA trial of its lead asset, milademetan for well-differentiated / dedifferentiated (WD/DD) liposarcoma (LPS).

RAIN